HPA
ANTH

Hilltop Park Associates’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Hilltop Park Associates’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-8,125
Closed -$234K – 36
2016
Q1 		$234K Sell
8,125
-3,125
-28% -$84.8K 0.52% 25
2015
Q4 		$418K Buy
11,250
+3,125
+38% +$138K 1.39% 17
2015
Q3 		$396K Buy
+8,125
New +$568K 5.96% 4

Other funds holding ANTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hilltop Park Associates's ANTH Position: Q3 2016 in Review

Hilltop Park Associates increased its Anthera Pharmaceuticals, Inc. (ANTH) stake by 33% in Q3 2016, buying an estimated $78.8K and bringing the position to 12,500 shares worth $315K. The position accounts for 0.58% of the portfolio, ranked #29.

Hilltop Park Associates first reported a position in ANTH in Q1 2015 and has held it in 7 quarters since. The position peaked at $1.03M in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q3 2016.

  • Hilltop Park Associates held 12,500 shares of Anthera Pharmaceuticals, Inc. worth $315K as of Q3 2016.
  • Hilltop Park Associates bought 3,125 Anthera Pharmaceuticals, Inc. shares in Q3 2016, an estimated $78.8K.
  • Anthera Pharmaceuticals, Inc. made up 0.58% of Hilltop Park Associates's portfolio in Q3 2016, its #29 holding.
  • Hilltop Park Associates first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2015 and has held it in 7 quarters since.
  • Hilltop Park Associates's Anthera Pharmaceuticals, Inc. position peaked at $1.03M in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2016.

Based on Hilltop Park Associates's 13F filing for Q3 2016, filed 10 Nov 2016.